Effects of prolonged oral administration of aflatoxin B1 and fumonisin B1 in broiler chickens.
The effects of prolonged oral administration of aflatoxin B1 (AFB1) and fumonisin B1 (FB1) mycotoxins were evaluated in broiler chickens from 21 to 42 d of age. A total of 192 birds were housed in experimental batteries and assigned to 32 cages, 6 birds per cage. The following treatments were applied: 1) 0 mycotoxins (control), 2) 10 mg of FB1, 3) 50 microg of AFB1, 4) 50 microg of AFB1 + 10 mg of FB1, 5) 350 microg of AFB1, 6) 350 microg of AFB1 + 10 mg of FB1, 7) 2,450 microg of AFB1, 8) 2,450 microg of AFB1 + 10 mg of FB1/kg of feed. Each treatment consisted of 4 replicates of 6 birds each. At the end of the trial, blood samples from 12 birds per treatment were collected, and the birds were necropsied. Compared with controls, the percentage of heterophils was lower (P < 0.05) in birds from groups receiving 50 microg of AFB1/kg + 10 mg of FB1/ kg and 2450 microg of AFB1/kg alone or in combination with FB1. A higher percentage of lymphocytes (P < 0.05) was observed in birds fed 50 microg of AFB1/kg + 10 mg of FB1/ kg, 350 microg of AFB1/kg, and 2,450 microg of AFB1/kg. A decrease in plasma albumin was observed only in birds fed 2,450 microg of AFB1/kg + 10 mg of FB1/kg. The liver of AFB1-treated birds had focal areas of necrosis and inflammatory infiltrates. In birds fed rations containing only 10 mg of FB1/kg, bile duct hyperplasia with fibrosis and a mononuclear infiltrate accompanied by trabecular derangement were observed. In contrast, in treatments in which FB1 was administered in combination, hepatic vacuolar degeneration was observed, and renal tissue presented corpuscles with increased cellular agglomeration, characterizing glomerulonephritis, and a clearly visible tubular epithelium with areas of degeneration and necrosis. The FB1 residues were detected in liver and in excreta of all FB1-treated groups, at levels that ranged from 0.013 to 0.051 mg/kg and from 1.19 to 2.79 mg/kg, respectively. Results indicated that FB1 and AFB1, singly or in combination at the levels evaluated, do not change markedly the hematological and serological parameters of broiler chickens, but may cause relevant lesions in liver and in kidneys.
Del Bianchi
M
M
Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP 05508-900, Brazil.
Oliveira
C A F
CA
Albuquerque
R
R
Guerra
J L
JL
Correa
B
B
D000284:Administration, Oral; D016604:Aflatoxin B1 / Q000008:administration & dosage / Q000032:analysis / Q000633:toxicity*; D000821:Animal Feed; D000818:Animals; D002645:Chickens / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004350:Drug Residues; D004906:Erythrocyte Count / Q000662:veterinary; D005243:Feces / Q000737:chemistry; D037341:Fumonisins / Q000008:administration & dosage / Q000032:analysis / Q000633:toxicity*; D006400:Hematocrit; D006454:Hemoglobins; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007958:Leukocyte Count / Q000662:veterinary; D008099:Liver / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D008297:Male; D011201:Poultry Diseases / Q000139:chemically induced / Q000473:pathology; D013997:Time Factors
D037341:Fumonisins; D006454:Hemoglobins; C056933:fumonisin B1; D016604:Aflatoxin B1